RESUMEN
Simultaneous blockade of the CD40 and CD28 costimulatory pathways is an effective treatment strategy to promote allograft acceptance but does not lead to indefinite allograft survival. The immune mechanisms responsible for costimulation-independent rejection are not defined. Here we have studied the rejection responses of murine C57BL/6 recipients, which we show to be relatively resistant to inhibition by combined CD40/CD28 blockade. We demonstrate that asialo GM1(+) CD8(+) cells play a critical role in this costimulation blockade-resistant rejection. These results provide new insights into the costimulatory requirements for T-cell subsets and demonstrate for the first time that combined blockade of the CD40 and CD28 pathways does not adequately inhibit CD8-mediated skin allograft rejection. Furthermore, we provide evidence that asialo GM1 is a potentially important therapeutic target for CD8-dependent immune responses.
Asunto(s)
Antígenos CD28/fisiología , Antígenos CD40/fisiología , Linfocitos T CD8-positivos/fisiología , Gangliósido G(M1)/fisiología , Rechazo de Injerto , Animales , Células Asesinas Naturales/fisiología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Receptores de Antígenos de Linfocitos T gamma-delta/análisis , Trasplante de Piel/inmunología , Trasplante HomólogoRESUMEN
Allograft rejection is dependent on T cell activation, which requires both the engagement of the T cell receptor by antigen in the context of the MHC molecules and costimulatory signals delivered by cell surface molecules such as B7-CD28/CTLA4 pathway. CTLA4-Ig is a fusion protein that blocks this pathway and has previously been shown to prolong both allograft and xenograft survival. The current study demonstrates markedly prolonged murine cardiac allograft survival and specific prolongation of secondary skin grafts using a combination of CTLA4-Ig plus donor bone marrow. A role for hematopoietic chimerism in the establishment of CTLA4-Ig-induced transplantation tolerance was investigated using reverse transcriptase polymerase chain reaction analysis of recipient tissues. Expression of donor-specific MHC class II transcripts in both peripheral and lymphoid tissues was demonstrated at greater than 200 days after transplant. To investigate the functional significance of this observation, heart donors, and donor bone marrow were irradiated before transplantation in CTLA4-Ig-treated recipients. A reduction in allograft survival was associated with irradiation of both the donor heart and the bone marrow. These results suggest that there may be a donor-derived radiosensitive element that enhances allograft survival in this model. Reverse transcriptase polymerase chain reaction analysis of allografts of tolerant and control animals at days 5, 8, and 12 after transplantation failed to demonstrate a dramatic difference in the expression of interleukin (IL)-2, IL-4, IL-10, and interferon-gamma message. Cytotoxicity effector transcripts were largely intact in CTLA4-Ig + bone marrow-treated recipients as they showed no decrease in intragraft granzyme, perforin, Fas, or Fas ligand transcripts during thr first 8 days after transplant. These results imply that complex mechanisms may be important for the induction and maintenance of transplantation tolerance in the CTLA4-Ig plus bone marrow murine cardiac allograft model.
Asunto(s)
Antígenos de Diferenciación/uso terapéutico , Trasplante de Médula Ósea , Supervivencia de Injerto , Tolerancia Inmunológica , Inmunoconjugados , Inmunosupresores/uso terapéutico , Abatacept , Animales , Antígenos CD , Secuencia de Bases , Antígeno CTLA-4 , Citocinas/genética , Trasplante de Corazón/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Tolerancia a Radiación , Trasplante de Piel , Trasplante HomólogoRESUMEN
Studies in vivo have documented the importance of CD40-gp39 interactions in the development of T-dependent antibody responses to foreign and auto-antigens. In this report, we demonstrate that allograft rejection is also associated with strong induction of CD40 and gp39 transcripts. When treatment was initiated at the time of transplant, MR1, a mAb specific for gp39, induced markedly prolonged survival of fully disparate murine cardiac allografts in both naive and sensitized hosts. However, when therapy was delayed until postoperative day 5, anti-gp39 failed to prolong graft survival. Allografts from recipients treated with MR1 from the time of transplantation showed decreased expression of transcripts for the macrophage effector molecule, inducible nitric oxide synthase, but essentially unaltered expression of B7 molecules and T cell cytokine transcripts (interleukin [IL]-2, interferon-gamma, IL-10, and IL-4) relative to control allografts. In addition, alloantibody responses in the MR1-treated mice were profoundly inhibited. However, our studies using B cell-deficient mice indicated that the ability of MR1 to prolong allograft survival was not dependent on B cells. These data suggest that blockade of CD40-gp39 interactions may inhibit allograft rejection primarily by interfering with T cell help for effector functions, rather than by interference with T cell activation.
Asunto(s)
Antígenos CD40/inmunología , Rechazo de Injerto/inmunología , Trasplante de Corazón/inmunología , Glicoproteínas de Membrana/inmunología , Linfocitos T/inmunología , Animales , Secuencia de Bases , Ligando de CD40 , Activación de Linfocitos , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Trasplante HomólogoRESUMEN
BACKGROUND: The prompt and vigorous immune response to xenogenic tissue remains a significant barrier to clinical xenotransplantation. Simultaneous blockade of the CD28 and CD40 costimulatory pathways has been shown to dramatically inhibit the immune response to alloantigen. METHODS: . In this study, we investigated the ability of simultaneous blockade of the CD28 and CD40 pathways to inhibit the immune response to xenoantigen in the rat-to-mouse and pig-to-mouse models. RESULTS: Simultaneous blockade of the CD28 and CD40 pathways produced marked inhibition of the cellular response to xenoantigen in vivo and produced long-term acceptance of xenogeneic cardiac and skin grafts (rat-to-mouse), and markedly suppressed an evoked antibody response to xenoantigen. In addition, this strategy significantly prolonged the survival of pig skin on recipient mice. CONCLUSIONS: Long-term hyporesponsiveness to xenoantigen across both a concordant and discordant species barrier, measured by the stringent criterion of skin grafting, can be achieved using a noncytoablative treatment regimen.
Asunto(s)
Antígenos CD28/inmunología , Antígenos CD40/inmunología , Supervivencia de Injerto/inmunología , Trasplante de Corazón/inmunología , Tolerancia Inmunológica/fisiología , Inmunoconjugados , Trasplante de Piel/inmunología , Trasplante Heterólogo/inmunología , Abatacept , Animales , Antígenos CD , Antígenos de Diferenciación/inmunología , Antígeno CTLA-4 , Trasplante de Corazón/patología , Antígenos de Histocompatibilidad Clase I/inmunología , Inmunosupresores/inmunología , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos DBA , Antígenos de Histocompatibilidad Menor , Ratas , Ratas Sprague-Dawley , Trasplante de Piel/patología , PorcinosRESUMEN
Negative-pressure dressings have been used in the treatment of a variety of open wounds, and as a bolster for skin grafts. The benefits of these dressings include increased oxygen tension in the wound, decreased bacterial counts, increased granulation formation, and the prevention of shear force on wounds. Also, by virtue of the diminished need for daily dressing changes, there are the additional advantages of enhancing patient comfort, decreasing nursing work, and diminished cost of wound care. Hidradenitis suppurativa (HS) is a chronic infection of the apocrine sweat glands. Treatment options range from oral isotretinoin to radical excision. Wound closure may be achieved by secondary intention, skin grafting, or flap closure. Complications may still arise and include disease progression and squamous cell carcinoma. Radical excision yields the best results in terms of disease eradication. The authors describe using the negative-pressure dressing in two cases of bilateral axillary HS to secure skin grafts firmly to the wound bed after radical excision of all involved tissues. Patient comfort and acceptance was high, and skin graft take was excellent. The dressings themselves are simple to apply and are highly effective.
Asunto(s)
Hidradenitis Supurativa/cirugía , Apósitos Oclusivos , Trasplante de Piel , Succión , Adulto , Axila/cirugía , Humanos , Masculino , Cuidados Posoperatorios , Cicatrización de Heridas/fisiologíaRESUMEN
Phlegmasia cerulea dolens (PCD) is the term describing the painful venous congestion that results from near-total venous occlusion of a limb. It is unusual in the lower extremity but is decidedly rare in the upper extremity with only a handful of cases reported in the literature. PCD of the upper extremity usually occurs in patients with significant comorbid conditions such as severe cardiac failure or advanced malignancy. PCD of the upper extremity is associated with substantial morbidity and mortality. We present a case of upper extremity PCD in an elderly man with a complex medical history, complicated clinical course, and poor outcome that is typical for this rare disease.
Asunto(s)
Tromboflebitis/terapia , Anciano , Amputación Quirúrgica , Brazo , Cateterismo Venoso Central , Resultado Fatal , Humanos , Enfermedades Pulmonares Obstructivas/complicaciones , Masculino , Enfermedad Cardiopulmonar/complicaciones , Terapia Trombolítica , Tromboflebitis/complicaciones , Insuficiencia del TratamientoRESUMEN
The use of tissue expanders has been described in numerous applications, including the closure of massive abdominal wall defects. The advantages of tissue expansion include providing adequate soft tissue for stable coverage of prosthetic material. In a subfascial plane, expanders can also expand muscle and fascia to allow total autologous repair of massive ventral hernias. These techniques for abdominal wall reconstruction are well established to cover viscera, to repair hernias, and to restore acceptable contour. The authors present the novel case of a woman with unstable skin graft coverage of a massive ventral hernia whose pregnancy was used as a surrogate intra-abdominal tissue expander to facilitate abdominal wall reconstruction.
Asunto(s)
Hernia Ventral/cirugía , Complicaciones del Embarazo , Expansión de Tejido , Adulto , Femenino , Humanos , Embarazo , Expansión de Tejido/métodosRESUMEN
BACKGROUND: Haemopoietic microchimerism has been identified in recipients of solid-organ transplants and is thought by some to be critical for the development and maintenance of immunological tolerance. The aim of this study was to correlate prospectively the persistence of donor cells with clinical outcome in recipients of kidney, kidney and pancreas, and liver transplants. METHODS: Persistence of donor cells in recipient peripheral blood was assessed at 3 days, and at 1, 3, 6, and 12 months after transplantation by a two-stage nested PCR technique to detect donor MHC HLA DR gene specifically. A pretransplant blood sample was collected from each patient to serve as an individual negative control. Seven liver, six kidney and pancreas, and 17 kidney patients were enrolled. 12 of the 17 kidney patients and all of the kidney and pancreas, and liver recipients were suitable for analysis. Exact matches for donors and recipients at the HLA DR loci (n = 1) or inability to obain primer pair specificity among similar HLA DR types (n = 4), meant that we were unable to analyse five patients. FINDINGS: Donor DNA was detected in 20 (80%) of 25, ten (40%) of 25, seven (30%) of 23, five (22%) of 23, and six (32%) of 19 recipients at 3 days, and 1, 3, 6 and 12 months post-transplant, respectively. Within individuals, the detection of donor DNA varied over time; only two patients had detectable donor DNA at all times. Analysis of the whole group of transplant patients showed a similar frequency and severity of rejection episodes in patients with and without microchimerism as defined by detectable donor DR genes. INTERPRETATION: These data suggest that a significant percentage of the recipients had persistent donor class II DNA in the peripheral circulation for at least 1 year after transplantation. We showed that a pretransplant blood sample is critical to avoid a false-positive result, and suggest that detectable chimerism may vary over time in individual patients. Therefore, analysis of microchimerism with a single, post-transplant analysis may not help in making clinical decisions for individual patients.
Asunto(s)
Rechazo de Injerto/inmunología , Supervivencia de Injerto/inmunología , Trasplante de Riñón/inmunología , Trasplante de Hígado/inmunología , Trasplante de Páncreas/inmunología , Quimera por Trasplante/inmunología , Antígenos HLA-DR/genética , Prueba de Histocompatibilidad , Humanos , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Factores de Tiempo , Resultado del TratamientoRESUMEN
It is postulated that IFN-gamma production hinders long-term acceptance of transplanted organs. To test this hypothesis, we compared survival of skin and heart allografts in wild-type (IFN-gamma+/+) mice to that in IFN-gamma gene knockout (IFN-gamma-/-) mice. We found that perioperative blockade of the CD28 and/or CD40 ligand T cell costimulation pathways induces long-term skin and heart allograft survival in IFN-gamma+/+ recipients but fails to do so in IFN-gamma-/- mice or in wild-type mice treated with IFN-gamma-neutralizing Ab at the time of transplantation. In vitro studies showed that endogenously produced IFN-gamma down-regulates T cell proliferation and CTL generation in MLCs. These actions of IFN-gamma were not mediated by TNF-alpha production or Fas-Fas ligand interactions. In vivo studies revealed exaggerated expansion and, subsequently, impaired deletion of superantigen-reactive T lymphocytes in IFN-gamma-/- mice injected with staphylococcal enterotoxin B. Taken together, our findings indicate that IFN-gamma does not hinder but instead facilitates induction of long-term allograft survival possibly by limiting expansion of activated T cells.
Asunto(s)
Antígenos CD28/inmunología , Antígenos CD40/inmunología , Supervivencia de Injerto , Inmunoconjugados , Inmunosupresores/administración & dosificación , Interferón gamma/fisiología , Activación de Linfocitos , Glicoproteínas de Membrana/antagonistas & inhibidores , Linfocitos T/inmunología , Abatacept , Animales , Antígenos CD , Antígenos de Diferenciación/administración & dosificación , Ligando de CD40 , Antígeno CTLA-4 , Supresión Clonal , Células Clonales , Citotoxicidad Inmunológica/efectos de los fármacos , Supervivencia de Injerto/efectos de los fármacos , Supervivencia de Injerto/genética , Trasplante de Corazón/inmunología , Humanos , Inyecciones Intraperitoneales , Interferón gamma/genética , Ligandos , Activación de Linfocitos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ratones Noqueados , Trasplante de Piel/inmunología , Linfocitos T Citotóxicos/inmunología , Trasplante HomólogoRESUMEN
The receptor-ligand pairs CD28-B7 and CD40-gp39 are essential for the initiation and amplification of T-cell-dependent immune responses. CD28-B7 interactions provide 'second signals' necessary for optimal T-cell activation and IL-2 production, whereas CD40-gp39 signals co-stimulate B-cell, macrophage, endothelial cell and T-cell activation. Nonetheless, blockade of either of these pathways alone is not sufficient to permit engraftment of highly immunogenic allografts. Here we report that simultaneous but not independent blockade of the CD28 and CD40 pathways effectively aborts T-cell clonal expansion in vitro and in vivo, promotes long-term survival of fully allogeneic skin grafts, and inhibits the development of chronic vascular rejection of primarily vascularized cardiac allografts. The requirement for simultaneous blockade of these pathways for effective inhibition of alloimmunity indicates that, although they are interrelated, the CD28 and CD40 pathways are critical independent regulators of T-cell-dependent immune responses.